Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 56 of 103, showing 5 Applications out of 512 total, starting on record 276, ending on 280

# Protocol No Study Title Investigator(s) & Site(s)

276.

ECCT/15/11/04   VAC040
    A Phase 1/2, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Tolerability, and Immunogenicity of Stretococcus pneumoniae Whole Cell Vaccine,read more
Principal Investigator(s)
1. John Anthony Gerard Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Program
 
View

277.

ECCT/18/12/01   study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants.
    A Phase 1b, open-label, age de-escalation, dose-escalationread more
Principal Investigator(s)
1. Mainga Hamaluba
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (read more
View

278.

ECCT/24/03/01   RAD-TB
    A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis   
Principal Investigator(s)
1. Dr Josphat Kosgei Kosgei
Site(s) in Kenya
Kenya medical research institute/ Walter Reed program KERICHO
 
View

279.

ECCT/24/02/02   Sabin 003
    A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral-read more
Principal Investigator(s)
1. Prof. Videlis Nduba Nzioka
Site(s) in Kenya
KEMRI / CRDR, KEMRI Clinical Research Annex, Siaya County Referral Hospital Ground.read more
View

280.

ECCT/22/07/01   GBT021601-021 Study
    A Phase 2/3 Randomized, Multicenter Study of GBT021601 Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study inread more
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Berhnards Ragama Ogutu
3. Videlis Nduba
4. Berhnards Ragama Ogutu
Site(s) in Kenyaread more
View